Skip to main content

Hemolytic-Uremic Syndrome clinical trials at UCSF

1 research study open to eligible people

Hemolytic-uremic syndrome is a rare kidney condition. UCSF is studying a medication called Crovalimab to see how safe and effective it is for people with this illness. The study also looks at how the body handles the drug.

Showing trials for

Last updated: